Latest Commercialisation News

Page 5 of 239
Gold Hydrogen says its Ramsay project has demonstrated helium flow across three wells, with concentrations averaging 15.2% and modelled potential of up to 37 Mscf per well per day. The technical progress comes with a sharper financial constraint: cash fell to A$3.96 million, equal to only 0.57 quarters of reported funding, while a capital raising remains in prospect.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Merino & Co. entered FY2027 with A$1.404 million in cash after a A$1.010 million capital raising, giving the company more room to develop its botanical dye project and expand fulfilment. The stronger balance sheet came alongside a A$164,000 operating cash outflow and fully drawn NAB loan facilities.
Victor Sage
Victor Sage
30 Oct 2026
Pure Resources has moved its Garnet Hills strategy from concept towards laboratory validation, with heavy rare earths recovered into solution, CNTF fabrics manufactured in-house and garnet meeting key abrasive standards. The milestones remain early-stage, with no quantified rare earth recovery or commercial revenue reported.
Victor Sage
Victor Sage
30 Oct 2026
Recce Pharmaceuticals has cleared an active-comparator design for its pivotal Australian diabetic foot infection trial while an independent review of Indonesian Phase 3 data approaches. The biotech ended the quarter with A$1.04 million in cash, alongside expected tax rebates and unused financing facilities.
Victor Sage
Victor Sage
30 Oct 2026
Jade Gas has progressed a proposed consortium-backed development for its Mongolian coal bed methane project, with 100% of Phase 1 capital expenditure potentially funded by a Chinese-led group. The opportunity is substantial, but the agreement remains non-binding and binding documents are now targeted for November.
Victor Sage
Victor Sage
30 Oct 2026
FirstWave Cloud Technology delivered positive EBITDA in its first FY27 quarter, but cash fell to just A$83,000 before a post-quarter A$1.06 million placement restored near-term liquidity. The company is now balancing product launches and AI commercialisation against A$1.3 million of contract renewals due in December.
Victor Sage
Victor Sage
30 Oct 2026
Terragen has completed the induction of 10,600 cattle into its largest feedlot trial and secured Brazilian approval for its probiotic feed additive. But customer receipts fell to $255,000 for the September quarter, while cash declined to $5.73 million amid a CEO departure and chair transition.
Ada Torres
Ada Torres
30 Oct 2026
NoviqTech says its Great Barrier Reef biochar project has passed harvesting, laboratory and Isometric eligibility assessments, while a potential offtake could cover at least 70% of planned credits. But the company ended September with A$151,000 in cash, an estimated 2.57 quarters of funding and no guarantee of returning to the ASX.
Victor Sage
Victor Sage
30 Oct 2026
Eden Innovations opened FY27 with US sales more than doubling to US$381,612, led by a sharp rise in OptiBlend orders and expanding EdenCrete plant installations. The company ended September with A$4.3 million in cash and no third-party debt, but still used A$892,000 in operating cash during the quarter.
Victor Sage
Victor Sage
30 Oct 2026
Epiminder has enrolled its 100th patient in the DETECT US epilepsy study ahead of schedule, while maintaining A$65.1 million in cash and no borrowings. The company says those reserves can fund clinical development and commercialisation work well into 2028.
Victor Sage
Victor Sage
30 Oct 2026
Mount Ridley Mines has expanded its inferred scandium resource at Grass Patch to 946.1 million tonnes, while laboratory testing lifted scandium recovery to 91.8% using roughly half the previous reagent dose. The gains come with an important qualification: the resource remains Inferred, gallium recovery fell in the latest test and scale-up work is still ahead.
Maxwell Dee
Maxwell Dee
30 Oct 2026
Estrella Resources has signed a binding agreement to sell 27,000 tonnes of manganese from its Ira Miri project in Timor-Leste, moving the bulk sample closer to shipment and customer testing. The deal marks commercial progress, but pricing remains confidential and no revenue will be recognised until delivery and payment occur.
Maxwell Dee
Maxwell Dee
30 Oct 2026

Browse the archive

Full archive